Dr. Roselle Abraham is a physician scientist with a background in electrophysiology, imaging and stem cell research. She is using multi-modality imaging for risk stratification of atrial and ventricular arrhythmias. The overall goal of her research program is to use a combination of multi-modality clinical imaging and studies in model systems to tailor therapies for patients with hypertrophic cardiomyopathy.
Dr. Marcus is Associate Chief of Cardiology for Research at UCSF Health. His particular research interests include cardiovascular effects of alcohol and caffeine and other common, modifiable, lifestyle factors; atrial fibrillation (mechanisms, guideline adherence, novel therapies); consequences and optimal management of cardiac ectopy (PACs and PVCs); supraventricular tachycardia (diagnoses and national treatment patterns); implantable cardiac devices (patient and provider knowledge and experiences, optimal performance, patient selection); with broader interests in clinical research study design and genetic epidemiology. More recently, as one of the leaders of the Health eHeart Study and the NIH-funded Eureka platform, Dr. Marcus' interests have included mobile health technology and leveraging devices, sensors, mobile apps and the internet to understand "real time" and "real life" effects and to conduct clinical research more efficiently.
Dr Gerstenfeld is the Melvin Scheinman Endowed Professor of Medicine and Chief of the Section of Cardiac Electrophysiology at UCSF. He is the Associate Editor of the Journal of Cardiac Electrophsyiology, is on the editorial board of multiple Cardiology/EP journals, has served 7 years on the ABIM CCEP board writing committee and the 2017 HRS/EHRA/ECAS/APHRS guideline committee for catheter and surgical ablation of atrial fibrillation.